Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.
OBJECTIVES To evaluate the efficacy and safety of upadacitinib in patients with anti-TNF -refractory intestinal Behçet's disease (BD). METHODS We conducted a single-center retrospective study using data from a maintained BD registry at Peking Union Medical College Hospital between July 2024 and April 2026. Seventeen...